Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, PR China.
Ren Fail. 2011;33(10):964-8. doi: 10.3109/0886022X.2011.615968.
A high body mass index (BMI) is a positive predictor of outcome in hemodialysis. But reports for peritoneal dialysis (PD) have been less numerous. The aim of the present investigation was to study the association between BMI and survival among PD patients and to discuss the main risk factors affecting survival.
A total of 159 patients who received PD from 1 January 2006 to 31 December 2010 at the Department of Nephrology in the Third Affiliated Hospital of Soochow University were enrolled in the study. Blood samples and baseline characteristics of the study cohort were obtained at the start of PD. Patient survival status was recorded through 31 December 2010.
Patients were stratified into two groups as normal weight (BMI, 18.5-24.9) and overweight (BMI, 25.0-29.9). Kaplan-Meier survival curve revealed that the normal weight patients had survival advantage over overweight patients (p < 0.01, by log-rank test). Cox proportional hazard models revealed that BMI, age, diabetes mellitus, coronary vascular disease, congestive heart failure and lipoprotein(a) (Lp(a)) were significant risk factors associated with all-cause mortality (p < 0.05). After adjustment for these covariates, survival was consistently higher for normal weight patients (p < 0.01). Furthermore, the study demonstrated that normal weight patients had lower serum Lp(a) (p < 0.05), C-reactive protein (CRP) (p < 0.05), and peritonitis rate (p < 0.05) compared with overweight patients.
The results indicated that normal BMI at the commencement of PD had significant survival advantage in our study. The mechanisms for this might be related to lower cardiovascular risk, less chronic inflammation, and peritonitis prevalence.
高身体质量指数(BMI)是血液透析患者预后的一个积极预测指标。但腹膜透析(PD)的相关报道则相对较少。本研究旨在探讨 PD 患者 BMI 与生存的相关性,并讨论影响生存的主要危险因素。
2006 年 1 月 1 日至 2010 年 12 月 31 日,苏州大学附属第三医院肾内科共收治 159 例 PD 患者。在开始 PD 时采集血样并获取研究队列的基线特征。通过 2010 年 12 月 31 日记录患者的生存状况。
患者被分为正常体重组(BMI,18.5-24.9)和超重组(BMI,25.0-29.9)。Kaplan-Meier 生存曲线显示,正常体重组患者的生存优势高于超重组(p<0.01,log-rank 检验)。Cox 比例风险模型显示,BMI、年龄、糖尿病、心血管疾病、充血性心力衰竭和脂蛋白(a)(Lp(a))是与全因死亡率相关的显著危险因素(p<0.05)。在调整这些协变量后,正常体重组患者的生存优势仍然存在(p<0.01)。此外,研究表明,与超重组相比,正常体重组患者的血清 Lp(a)(p<0.05)、C 反应蛋白(CRP)(p<0.05)和腹膜炎发生率(p<0.05)均较低。
本研究表明,PD 开始时正常的 BMI 对患者的生存有显著优势。其机制可能与较低的心血管风险、较少的慢性炎症和腹膜炎发生率有关。